Literature DB >> 9667434

Role of acoustic striae in hearing: discrimination of sound-source elevation.

D P Sutherland1, K K Glendenning, R B Masterton.   

Abstract

After years of systematic experimentation, we finally uncovered one thing the dorsal system contributes to hearing which the ventral system may not -- the mechanism for orienting to an elevated sound source [Sutherland, D.P., Masterton, R.B., Glendenning, K.K. (1998) Behav. Brain Res. in press]. This paper follows up this one positive result on a historical background of uniformly negative results. The focus of this report is on the fusiform cells of the dorsal cochlear nucleus whose axons course through the dorsal acoustic stria (DAS). Because electrophysiological studies have shown that the cues for sensing the elevation of a sound source would seem to be best analyzed by the dorsal cochlear nucleus, we tested, behaviorally, normal cats and cats deprived of their DAS or intermediate acoustic stria, bilaterally or ipsilaterally (with or without their contralateral ear deafened), for their ability to orient to elevated sources of broad-band noise. For behavioral testing, we made use of a conventional shock-avoidance procedure. The results lead to the conclusion that DCN and DAS may play no role in learned elevation discriminations. This result builds on that of another of our papers which suggests that a deficit in reflexive discrimination of elevation is strictly auditory in nature [Sutherland, D.P., Masterton, R.B., Glendenning, K.K. (1998) Behav. Brain Res. in press].

Entities:  

Mesh:

Year:  1998        PMID: 9667434     DOI: 10.1016/s0378-5955(98)00056-2

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  12 in total

1.  Single-neuron recordings from unanesthetized mouse dorsal cochlear nucleus.

Authors:  Wei-Li Diana Ma; Stephan D Brenowitz
Journal:  J Neurophysiol       Date:  2011-11-09       Impact factor: 2.714

2.  Age-related changes in glycine receptor subunit composition and binding in dorsal cochlear nucleus.

Authors:  H Wang; J G Turner; L Ling; J L Parrish; L F Hughes; D M Caspary
Journal:  Neuroscience       Date:  2009-02-13       Impact factor: 3.590

3.  On the role of the wideband inhibitor in the dorsal cochlear nucleus: a computational modeling study.

Authors:  Oleg Lomakin; Kevin A Davis
Journal:  J Assoc Res Otolaryngol       Date:  2008-08-14

4.  Dorsal Cochlear Nucleus Fusiform-cell Plasticity is Altered in Salicylate-induced Tinnitus.

Authors:  David T Martel; Thibaut R Pardo-Garcia; Susan E Shore
Journal:  Neuroscience       Date:  2018-09-12       Impact factor: 3.590

5.  Serotonergic regulation of excitability of principal cells of the dorsal cochlear nucleus.

Authors:  Zheng-Quan Tang; Laurence O Trussell
Journal:  J Neurosci       Date:  2015-03-18       Impact factor: 6.167

6.  Spontaneous spiking and synaptic depression underlie noradrenergic control of feed-forward inhibition.

Authors:  Sidney P Kuo; Laurence O Trussell
Journal:  Neuron       Date:  2011-07-28       Impact factor: 17.173

Review 7.  Timing is everything: temporal processing deficits in the aged auditory brainstem.

Authors:  Joseph P Walton
Journal:  Hear Res       Date:  2010-03-18       Impact factor: 3.208

Review 8.  Mechanisms of synaptic plasticity in the dorsal cochlear nucleus: plasticity-induced changes that could underlie tinnitus.

Authors:  Thanos Tzounopoulos
Journal:  Am J Audiol       Date:  2008-10-31       Impact factor: 1.493

9.  Coactivation of pre- and postsynaptic signaling mechanisms determines cell-specific spike-timing-dependent plasticity.

Authors:  Thanos Tzounopoulos; Maria E Rubio; John E Keen; Laurence O Trussell
Journal:  Neuron       Date:  2007-04-19       Impact factor: 17.173

10.  Atypical vertical sound localization and sound-onset sensitivity in people with autism spectrum disorders.

Authors:  Eelke Visser; Marcel P Zwiers; Cornelis C Kan; Liesbeth Hoekstra; A John van Opstal; Jan K Buitelaar
Journal:  J Psychiatry Neurosci       Date:  2013-11       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.